Show simple item record

dc.contributor.authorTucker, Joseph D.
dc.contributor.authorMeyers, Kathrine
dc.contributor.authorBest, John
dc.contributor.authorKaplan, Karyn
dc.contributor.authorPendse, Razia
dc.contributor.authorFenton, Kevin A.
dc.contributor.authorOcama, Ponsiano
dc.contributor.authorPeeling, Rosanna
dc.contributor.authorWalsh, Nick
dc.contributor.authorColombo, Massimo G.
dc.contributor.authorEasterbrook, Philippa
dc.date.accessioned2022-05-01T21:18:05Z
dc.date.available2022-05-01T21:18:05Z
dc.date.issued2017
dc.identifier.citationTucker, J. D., Meyers, K., Best, J., Kaplan, K., Pendse, R., Fenton, K. A., ... & Easterbrook, P. (2017). The HepTestContest: a global innovation contest to identify approaches to hepatitis B and C testing. BMC infectious diseases, 17(1), 177-185. DOI 10.1186/s12879-017-2771-4en_US
dc.identifier.other10.1186/s12879-017-2771-4
dc.identifier.urihttps://nru.uncst.go.ug/handle/123456789/3102
dc.description.abstractInnovation contests are a novel approach to elicit good ideas and innovative practices in various areas of public health. There remains limited published literature on approaches to deliver hepatitis testing. The purpose of this innovation contest was to identify examples of different hepatitis B and C approaches to support countries in their scale-up of hepatitis testing and to supplement development of formal recommendations on service delivery in the 2017 World Health Organization hepatitis B and C testing guidelines. Methods: This contest involved four steps: 1) establishment of a multisectoral steering committee to coordinate a call for contest entries; 2) dissemination of the call for entries through diverse media (Facebook, Twitter, YouTube, email listservs, academic journals); 3) independent ranking of submissions by a panel of judges according to prespecified criteria (clarity of testing model, innovation, effectiveness, next steps) using a 1-10 scale; 4) recognition of highly ranked entries through presentation at international conferences, commendation certificate, and inclusion as a case study in the WHO 2017 testing guidelines. Results: The innovation contest received 64 entries from 27 countries and took a total of 4 months to complete. Sixteen entries were directly included in the WHO testing guidelines. The entries covered testing in different populations, including primary care patients (n = 5), people who inject drugs (PWID) (n = 4), pregnant women (n = 4), general populations (n = 4), high-risk groups (n = 3), relatives of people living with hepatitis B and C (n = 2), migrants (n = 2), incarcerated individuals (n = 2), workers (n = 2), and emergency department patients (n = 2). A variety of different testing delivery approaches were employed, including integrated HIV-hepatitis testing (n = 12); integrated testing with harm reduction and addiction services (n = 9); use of electronic medical records to support targeted testing (n = 8); decentralization (n = 8); and task shifting (n = 7). Conclusion: The global innovation contest identified a range of local hepatitis testing approaches that can be used to inform the development of testing strategies in different settings and populations. Further implementation and evaluation of different testing approaches is needed.en_US
dc.language.isoenen_US
dc.publisherBMC infectious diseasesen_US
dc.subjectHepTestContesten_US
dc.subjectInnovation contesten_US
dc.subjectHepatitis Ben_US
dc.titleThe HepTestContest: a global innovation contest to identify approaches to hepatitis B and C testingen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record